Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine Treatment
Stéphane Bonnet, Dana M. Hartl, Sophie Leboulleux et al. · The Journal of Clinical Endocrinology & Metabolism · 2008
OBJECTIVE: Prophylactic neck dissection for small papillary carcinoma remains controversial. Radioiodine ablation is not recommended for tumors less than 10 mm and depends on various factors for tumors between 10 and 20 mm. The aim was to determine the effect of lymph node (LN) staging on the indication for treatment with radioiodine. PATIENTS AND METHODS: We conducted a retrospective study of 115 patients presenting with papillary thyroid carcinoma less than 2 cm without ultrasonographically detectable cervical LN treated by total thyroidectomy and complete selective dissection of the central and lateral compartment. Radioiodine treatment was based on definitive pathology (tumor and LN). Follow-up was based on neck ultrasound and thyroglobulin levels. RESULTS: LN were found for 41.7% of cases. Radioiodine was not used for 42% of patients with tumors less than 20 mm and no metastatic LN. Fifty-eight percent of patients were treated with radioiodine due to LN metastasis, extracapsular thyroid invasion, or unfavorable histological subtype. LN status affected the indication for radioiodine in 30.5% of cases classified as T1, 12 cases with tumors less than 10 mm but with LN metastases (who received radioiodine), and 13 cases with tumors between 10 and 20 mm but without LN metastases (who did not receive radioiodine). Definitive vocal fold paralysis and hypoparathyroidism each occurred in 0.9% of cases. At 1 yr, ultrasound was normal in all patients, and recombinant human TSH-stimulated thyroglobulin was undetectable for 97% of the patients. CONCLUSION: Precise LN staging by prophylactic neck dissection for tumors initially staged T1N0 modified the indication for radioiodine ablation for 30% of patients.
Cited by 275 works. doi:10.1210/jc.2008-1931 Open-access PDF
Authors
- Stéphane Bonnet
- Dana M. Hartl
- Sophie Leboulleux
- Éric Baudin
- J. Lumbroso
- Abir Al Ghuzlan
- L. Chami
- Martin Jean Schlumberger
- Jean‐Paul Travagli
References
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
- Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
- Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
- An Observation Trial Without Surgical Treatment in Patients with Papillary Microcarcinoma of the Thyroid
- Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer
- Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
- Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery
- Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients
- Parathyroid Autotransplantation During Thyroidectomy